Ontology highlight
ABSTRACT:
SUBMITTER: Oehlrich D
PROVIDER: S-EPMC6691570 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Oehlrich Daniel D Peschiulli Aldo A Tresadern Gary G Van Gool Michiel M Vega Juan Antonio JA De Lucas Ana Isabel AI Alonso de Diego Sergio A SA Prokopcova Hana H Austin Nigel N Van Brandt Sven S Surkyn Michel M De Cleyn Michel M Vos Ann A Rombouts Frederik J R FJR Macdonald Gregor G Moechars Dieder D Gijsen Harrie J M HJM Trabanco Andrés A AA
ACS medicinal chemistry letters 20190702 8
Despite several years of research, only a handful of β-secretase (BACE) 1 inhibitors have entered clinical trials as potential therapeutics against Alzheimer's disease. The intrinsic basic nature of low molecular weight, amidine-containing BACE 1 inhibitors makes them far from optimal as central nervous system drugs. Herein we present a set of novel heteroaryl-fused piperazine amidine inhibitors designed to lower the basicity of the key, enzyme binding, amidine functionality. This study resulted ...[more]